Literature DB >> 12088111

Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia.

J Bartkowiak1, D Kulczyck-Wojdala, J Z Blonski, T Robak.   

Abstract

To characterize circulating gammadelta T cell subpopulations in B chronic lymphocytic leukaemia patients (n=30), TCR Vgamma and Vdelta gene-segment use was analyzed by RT-PCR using a panel of subfamily-specific oligonucleotide primers. All results were compared with those obtained with specimens from healthy donors (n=10). The cells expressing Vdelta1+ TCR displayed the highest relative increase in B-CLL patients (particularly observed in 60% of cases), but Vdelta3+ T lymphocytes also expanded in leukaemic peripheral blood (10% of studied cases). Both mentioned gammadelta T cell subsets were significantly more frequent in the most severe stages of disease--Rai III+IV. The analysis of Vgamma region usage in TCR formation revealed that gammadelta T cells from B-CLL patients predominantly expressed a Vgamma9 segment (26 of 30 cases), usually linked to Cgamma1 region. It should be noticed that the dominant TCR genes expression in a 50% of healthy donors was Vdelta2+/Vgamma9+, however, Vgamma4 and Vgamma8 transcripts were also observed (2 and 3 of 10 cases, respectively). The above results indirectly indicate that gammadelta T lymphocyte expansion was driven by the oligo- or polyclonal proliferation and can reflect specific response against the autologous tumor cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088111

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  13 in total

1.  Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells.

Authors:  Bozgana A Mangan; Margaret R Dunne; Vincent P O'Reilly; Pádraic J Dunne; Mark A Exley; Donal O'Shea; Emmanuel Scotet; Andrew E Hogan; Derek G Doherty
Journal:  J Immunol       Date:  2013-06-05       Impact factor: 5.422

2.  Anti-leukemia activity of human gamma delta T cells.

Authors:  Gabrielle M Siegers
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

3.  Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.

Authors:  Zhenyi Jin; Qiang Luo; Shuai Lu; Xinyu Wang; Zifan He; Jing Lai; Shaohua Chen; Lijian Yang; Xiuli Wu; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2016-11-18       Impact factor: 17.388

Review 4.  Human γδT-cell subsets and their involvement in tumor immunity.

Authors:  Dang Wu; Pin Wu; Fuming Qiu; Qichun Wei; Jian Huang
Journal:  Cell Mol Immunol       Date:  2016-11-28       Impact factor: 11.530

Review 5.  Human αβ and γδ T Cells in Skin Immunity and Disease.

Authors:  Michelle S Cruz; Alani Diamond; Astrid Russell; Julie Marie Jameson
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

Review 6.  γδ T-cell responses during HIV infection and antiretroviral therapy.

Authors:  Jennifer A Juno; Emily M Eriksson
Journal:  Clin Transl Immunology       Date:  2019-07-17

Review 7.  Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.

Authors:  Nilberto Dias de Araújo; Fábio Magalhães Gama; Mateus de Souza Barros; Thaís Lohana Pereira Ribeiro; Fabíola Silva Alves; Lilyane Amorim Xabregas; Andréa Monteiro Tarragô; Adriana Malheiro; Allyson Guimarães Costa
Journal:  J Immunol Res       Date:  2021-01-07       Impact factor: 4.818

Review 8.  The Unknown Unknowns: Recovering Gamma-Delta T Cells for Control of Human Immunodeficiency Virus (HIV).

Authors:  Shivkumar Biradar; Michael T Lotze; Robbie B Mailliard
Journal:  Viruses       Date:  2020-12-17       Impact factor: 5.818

Review 9.  The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.

Authors:  Yang Li; Gen Li; Jian Zhang; Xiaoli Wu; Xi Chen
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

10.  The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.

Authors:  Liang Wang; Meng Xu; Chunyan Wang; Lihua Zhu; Junyan Hu; Shaohua Chen; Xiuli Wu; Bo Li; Yangqiu Li
Journal:  J Immunol Res       Date:  2014-05-21       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.